“I had never set foot in Buffalo and had no connections here. People ask me, ‘Why did you choose Roswell then?’ It’s simple: the people."
When you think of clinical research, you may picture doctors and scientists collecting data or patients trying new treatment regimens. However, some very important people are missing from this picture: clinical research nurses.
Candace Johnson, PhD, President and CEO of Roswell Park Comprehensive Cancer Center, didn’t imagine becoming a scientist when she was young. She wanted to be a ballerina.
When asked what interests her more about her work – being a clinician or a researcher – Dr. Griffiths answers that both do.
“I experienced the wonderful feeling of being able to provide real hope to people suffering from cancer.”
Among other projects, she and her colleagues are looking for ways to harness the power of stress to make allogeneic bone marrow transplants safer, improve outcomes for radiation and immunotherapies, and provide a new treatment strategy for patients with advanced melanoma.
Dr. Wooten's grandfather was diagnosed with metastatic lung cancer the summer before she began her medical education at the University of Florida College of Medicine. Her family's experience during that time has shaped the way she cares for her own patients at Roswell Park.
In 2019, Pamela Hershberger, PhD, came upon a stunningly significant finding in her research lab. Dr. Hershberger, Associate Professor of Oncology in Roswell Park’s Department of Pharmacology and Therapeutics, says she and her team had been “studying patients with a particular type of lung cancer — EGFR mutant lung cancer — and their response to a specific class of drugs called EGFR tyrosine kinase inhibitors.
Ask Joyce Ohm, PhD, Associate Professor of Oncology at Roswell Park Comprehensive Cancer Center, why she chose a challenging career focusing on epigenetics and her answer comes back sure and clear: “My mom died of a rare form of cancer when I was 10, and I made it my life
Roswell Park’s Christine Ambrosone, PhD, admits she may not have pursued the most conventional route to becoming a leading breast cancer researcher.
"It’s the potential to provide simple and effective methods to protect against disease and cancer. That’s what has always been very important to me.”